haemostasis + thrombophilia Flashcards
decreased haptoglobin can indicate
intravascular haemolysis
haemostasis
arrest of bleeding + maintenance of vascular patency
components of normal haemostatic system
- formation of platelet plug - primary haemostasis
- formation of fibrin clot - secondary
- fibrinolysis
- anticoagulant defences
formation of platelet plug
damage to blood vessel exposes collagen, von willebrand factor binds to collagen acting as an anchor for platelets to join
- platelets adhere via vWF - they activate + degranulate, shape changes + release chemicals that keeps vessel constricted + draw more platelets in
following formation of platelet plug, coagulation is activated to form a fibrin mesh which stabilises the platelet plug (secodary haemostasis)
causes of failure of platelet plug
vascular
platelets - reduced (thrombocytopenia), reduced function
von willebrand factor
consequences of failure of platelet plug
easy brusing, purpura
epistaxis, GI, conjuctival
menorrhagia
intracranial haemorrhages
retinal haemorrhages
screening tests for primary haemostasis
platelet count
causes of failed fibrin clot formation
single clotting factor deficiency - usally hereditary (haemophilia)
multiple clotting factor deficiencies - usually acquired (DIC)
increased fibrinolysis - usually part of complex coagulopathy
naturally occuring anticoagulants
- serine protease inhibitors
- protein C + protein S - switch off factor 5 + factor 8
thrombophilia
where there is increased risk of vvenous thrombosis due to dysregulation of coagulation system
can be hereditary or acquired
causes of hereditary thrombophilias
Factor V Leiden = commonest
prothrombin 20210 mutation
antithrombin deficiency
protein C / S deficiency (normally inactivates V+VIII, south east asian population)
when should hereditary thrombophilia screening be considered?
venous thrombosis <45y/o
recurrent venous thrombosis
unusual benous thrombosis
fam history of venous thrombosis
fam history of thrombophilia
factor V leiden (activated protein C resistence)
commonest inherited thrombophilia
autosomal dominant (but incomplete penetrance - not all with mutation are affected)
missense mutation where activated factor V is inactivated 10 times more slowly by activated protein C than normal (becomes resistanct to inactivation by protein C)
heterozygotes - 4-5 risk of VTW
homo - 10 fold risk
causes of acquired thrombophilias
antiphospholipid syndrome
drugs - COCP
antiphopholipid syndrome
acquired disorder with predisposition to venous + arterial thromboses, recurrent fetal loss + thrombocytopenia
can be primary or secondary to SLE
antiphospholipid investigations
anticardiolipin antibodies, anti-beta2-GPI antibodies or positive lupus anticoagulant assay
thromobocytopenia
prolonged aPPT